ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 94 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,000 | -77.4% | 20,987 | 0.0% | 0.00% | -66.7% |
| Q1 2018 | $31,000 | +19.2% | 20,987 | +16.7% | 0.00% | 0.0% |
| Q4 2017 | $26,000 | -36.6% | 17,987 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $41,000 | +70.8% | 17,987 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $24,000 | -51.0% | 17,987 | -21.8% | 0.00% | -40.0% |
| Q1 2017 | $49,000 | -48.4% | 22,987 | +7.0% | 0.01% | -54.5% |
| Q4 2016 | $95,000 | -8.7% | 21,487 | 0.0% | 0.01% | -8.3% |
| Q3 2016 | $104,000 | +92.6% | 21,487 | +30.3% | 0.01% | +100.0% |
| Q2 2016 | $54,000 | -8.5% | 16,487 | 0.0% | 0.01% | -14.3% |
| Q1 2016 | $59,000 | – | 16,487 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 289,664 | $434,000 | 0.43% |
| SALZHAUER MICHAEL | 220,153 | $330,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,644,583 | $2,467,000 | 0.08% |
| Brown Advisory Securities, LLC | 272,000 | $408,000 | 0.08% |
| Par Capital Management | 4,431,301 | $6,647,000 | 0.07% |
| ISTHMUS PARTNERS, LLC | 176,170 | $264,000 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 96,429 | $145,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 262,544 | $394,000 | 0.02% |
| Ballentine Partners, LLC | 100,000 | $150,000 | 0.01% |
| NWAM LLC | 20,000 | $30,000 | 0.01% |